Insider · CIK 0001872564
Amy L. Burroughs
directorceoofficer
Files at TERN (Terns Pharmaceuticals, Inc.), TNYA (Tenaya Therapeutics, Inc.). First filing Dec 9, 2024, latest Jun 25, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$203k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | TERNbuy Terns Pharmaceuticals, Inc. | $90k 23,314 shares | +98% | - | |
| 33Weak | Terns Pharmaceuticals, Inc. | $2,606 510 shares | +3% | - | |
| 58Moderate | Terns Pharmaceuticals, Inc. | $110k 15,450 shares | +423% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +23,314 | $3.87 | $90k | 47,083 | Jun 25, 2025 |
| May 29, 2025 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +107,400 | $0.00 | $0 | 107,400 | May 30, 2025 |
| Nov 30, 2024 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +510 | $5.11 | $2,606 | 19,609 | Feb 3, 2025 |
| Jan 30, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +1,075,000 | $0.00 | $0 | 1,075,000 | Feb 3, 2025 |
| Dec 5, 2024 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +15,450 | $7.15 | $110k | 19,099 | Dec 9, 2024 |
| Oct 18, 2024 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +34,000 | $0.00 | $0 | 34,000 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.